For Rick Doblin, 2023 might be a landmark 12 months: the year the US government decides irrespective of whether it allows the usage of hallucinogenic drugs to treat mental ailment.Estimating risk of long-term deleterious effects of discrete doses of MDMA in a controlled setting compared to retrospective studies in people reporting ecstasy use is in